This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ciproflox-Dexameth Otic Suspension, a medical product, with a ceiling value of $1,644.90 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ciproflox-Dexameth Otic Suspension 7.5ML. The contract has a firm fixed price, a ceiling value of $1,383.10, and a period of performance through May 6, 2025. This contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,890.13, is for the delivery of Ciproflox-Dexameth Otic Suspension 7.5 mL, a specialty pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $2,605.17, and a period of performance through April 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5 mL, a specialty pharmaceutical product. The contract has a ceiling value of $1,100.20 and a period of performance through May 1, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, with a ceiling value of $1,569.12 and a period of performance through May 14, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award is for a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ciprofloxacin-Dexamethasone Otic Suspension, a specialty medication, and has a ceiling value of $14,833.01. The contract is a Firm Fixed Price Delivery Order with a completion date of July 8, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ciproflox-Dexameth Otic Suspension 7.5 mL. The contract has a ceiling value of $1,567.17 and an ultimate completion date of December 11, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ciprofloxacin-Dexamethasone Otic Suspension, a pharmaceutical product used for the treatment of ear infections. The contract has a ceiling value of $7,019.94 and a completion date of April 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,114.88, is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...